Bioxytran, Inc.
BIXT
$0.077
-$0.0068-8.12%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.22M | -2.92M | -2.13M | -2.65M | -3.46M |
| Total Depreciation and Amortization | 8.80K | 7.80K | 7.90K | 8.80K | 9.10K |
| Total Amortization of Deferred Charges | 647.80K | 677.80K | 677.80K | 55.00K | 30.00K |
| Total Other Non-Cash Items | 448.60K | 780.40K | 399.10K | 354.10K | 663.40K |
| Change in Net Operating Assets | 944.10K | 1.29M | 936.50K | 1.99M | 2.14M |
| Cash from Operations | -173.70K | -163.30K | -105.60K | -242.30K | -615.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.40K | -20.50K | -26.50K | -21.00K | -24.60K |
| Cash from Investing | -36.40K | -20.50K | -26.50K | -21.00K | -24.60K |
| Total Debt Issued | 199.60K | 115.10K | 48.10K | 109.60K | 109.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 63.00K | 63.00K | 108.00K | 498.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 199.60K | 178.10K | 111.10K | 217.60K | 608.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.30K | -5.60K | -20.90K | -45.60K | -31.70K |